These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11720609

  • 1. Hypertrophic cardiomyopathy: therapeutic approaches.
    Thomas B.
    Heart Dis; 1999; 1(2):91-7. PubMed ID: 11720609
    [Abstract] [Full Text] [Related]

  • 2. [On the work by S. Reith and H. G. Klues "Therapy and risk-stratification in hypertrophic cardiomyopathy", Z Kardiol 92: 283-293 (2003)].
    Schwab J, Bareiter T, Bär I, Gottwik M.
    Z Kardiol; 2003 Sep; 92(9):763. PubMed ID: 14508595
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].
    Reith S, Klues HG.
    Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiology and treatment of hypertrophic cardiomyopathy.
    Sherrid MV.
    Prog Cardiovasc Dis; 2006 Apr; 49(2):123-51. PubMed ID: 17046437
    [Abstract] [Full Text] [Related]

  • 5. [Cardiac pacemaker for the treatment of obstructive hypertrophic cardiomyopathy, a concept which is gaining ground].
    Kappenberger L, Jeanrenaud X, Aebischer N.
    Schweiz Med Wochenschr; 1995 Oct 14; 125(41):1950-5. PubMed ID: 7481653
    [Abstract] [Full Text] [Related]

  • 6. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar 14; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 7. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.
    Am J Cardiol; 2009 Jul 01; 104(1):128-32. PubMed ID: 19576333
    [Abstract] [Full Text] [Related]

  • 8. Management of symptoms in hypertrophic cardiomyopathy.
    Fifer MA, Vlahakes GJ.
    Circulation; 2008 Jan 22; 117(3):429-39. PubMed ID: 18212300
    [No Abstract] [Full Text] [Related]

  • 9. [Management of refractory symptoms in hypertrophic cardiomyopathy with restrictive pathophysiology: novel perspectives for ranolazine].
    Tomberli B, Girolami F, Coppini R, Ferrantini C, Rossi A, Cecchi F, Olivotto I.
    G Ital Cardiol (Rome); 2012 Apr 22; 13(4):297-303. PubMed ID: 22495647
    [Abstract] [Full Text] [Related]

  • 10. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr 22; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 11. Hypertrophic cardiomyopathy. Pathophysiology, diagnosis, and treatment.
    Popjes ED, St John Sutton M.
    Geriatrics; 2003 Mar 22; 58(3):41-6; quiz 47. PubMed ID: 12650117
    [Abstract] [Full Text] [Related]

  • 12. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M, Ben Ameur I, Kechida Z, Charfeddine H, Hached L, Grati Z, Kammoun S.
    Tunis Med; 2003 Mar 22; 81 Suppl 8():675-9. PubMed ID: 14608758
    [Abstract] [Full Text] [Related]

  • 13. Asystole and scarring of the interventricular septum in hypertrophic cardiomyopathy.
    Foley PW, Frenneaux MP, Leyva F.
    J Cardiovasc Med (Hagerstown); 2009 Apr 22; 10(4):349-51. PubMed ID: 19430348
    [Abstract] [Full Text] [Related]

  • 14. [Long-term follow-up of hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillators].
    González-Enríquez S, Rodríguez-Entem F, Olalla JJ, Casanova MA.
    Rev Esp Cardiol; 2007 May 22; 60(5):552-3. PubMed ID: 17535769
    [No Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
    Jayatilleke I, Doolan A, Ingles J, McGuire M, Booth V, Richmond DR, Semsarian C.
    Am J Cardiol; 2004 May 01; 93(9):1192-4. PubMed ID: 15110224
    [Abstract] [Full Text] [Related]

  • 16. Ventricular tachycardia triggered by blanked flutter search-mediated cycle length alternation.
    Chang HC, Huang HL, Yeh KH.
    Europace; 2011 Jun 01; 13(6):875. PubMed ID: 21398314
    [No Abstract] [Full Text] [Related]

  • 17. [Pacemaker stimulation in dilated and hypertrophic myocardiopathies: should its use be stratified?].
    López Meneses M, Olvera Cruz S.
    Arch Cardiol Mex; 2002 Jun 01; 72 Suppl 1():S117-21. PubMed ID: 12001828
    [Abstract] [Full Text] [Related]

  • 18. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A, Małecka L, Pytkowski M, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Ruzyłło W, Szwed H.
    Kardiol Pol; 2005 Oct 01; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of hypertrophic cardiomyopathy].
    Havndrup O, Bundgaard H, Hansen FV, Pietersen AH, Kelbaek HS.
    Ugeskr Laeger; 1998 Sep 14; 160(38):5495-500. PubMed ID: 9763923
    [Abstract] [Full Text] [Related]

  • 20. Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment.
    Musat D, Sherrid MV.
    Anadolu Kardiyol Derg; 2006 Dec 14; 6 Suppl 2():9-17. PubMed ID: 17162264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.